Clinical trial
Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)
NCT02821572 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 2, 2014
- Completion date
- September 30, 2024
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune thrombocytopenia